The Cooper Cos., Inc. (COO)
75.81
-0.41
(-0.54%)
USD |
NASDAQ |
Aug 24, 16:00
75.92
+0.11
(+0.15%)
After-Hours: 20:00
Cooper Cos. EPS Diluted (Quarterly) : -0.3995 for April 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -0.3995 |
| January 31, 2026 | 0.665 |
| October 31, 2025 | 0.4271 |
| July 31, 2025 | 0.4915 |
| April 30, 2025 | 0.437 |
| January 31, 2025 | 0.5184 |
| October 31, 2024 | 0.5843 |
| July 31, 2024 | 0.5219 |
| April 30, 2024 | 0.4434 |
| January 31, 2024 | 0.4062 |
| October 31, 2023 | 0.4234 |
| July 31, 2023 | 0.4274 |
| April 30, 2023 | 0.1998 |
| January 31, 2023 | 0.4256 |
| October 31, 2022 | 0.3306 |
| July 31, 2022 | 0.496 |
| April 30, 2022 | 0.6368 |
| January 31, 2022 | 0.4775 |
| October 31, 2021 | 0.5593 |
| July 31, 2021 | 3.091 |
| April 30, 2021 | 0.591 |
| January 31, 2021 | 10.57 |
| October 31, 2020 | 0.4093 |
| July 31, 2020 | 0.2788 |
| April 30, 2020 | 0.058 |
| Date | Value |
|---|---|
| January 31, 2020 | 0.4552 |
| October 31, 2019 | 0.605 |
| July 31, 2019 | 0.5993 |
| April 30, 2019 | 0.612 |
| January 31, 2019 | 0.517 |
| October 31, 2018 | 0.504 |
| July 31, 2018 | 0.507 |
| April 30, 2018 | 0.307 |
| January 31, 2018 | -0.6263 |
| October 31, 2017 | 0.4457 |
| July 31, 2017 | 0.5222 |
| April 30, 2017 | 0.5298 |
| January 31, 2017 | 0.3836 |
| October 31, 2016 | 0.307 |
| July 31, 2016 | 0.4485 |
| April 30, 2016 | 0.3793 |
| January 31, 2016 | 0.2629 |
| October 31, 2015 | 0.1865 |
| July 31, 2015 | 0.2282 |
| April 30, 2015 | 0.3087 |
| January 31, 2015 | 0.3116 |
| October 31, 2014 | 0.1599 |
| July 31, 2014 | 0.45 |
| April 30, 2014 | 0.4059 |
| January 31, 2014 | 0.3665 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 1.103 |
| West Pharmaceutical Services, Inc. | 2.160 |
| Abbott Laboratories | 0.5324 |
| Stryker Corp. | 3.306 |
| Solventum Corp. | 0.5309 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -77.90M |
| Revenue (Quarterly) | 1.082B |
| Total Expenses (Quarterly) | 1.159B |
| Enterprise Value | 17.18B |
| Gross Profit Margin (Quarterly) | 63.59% |
| Profit Margin (Quarterly) | -7.20% |
| Earnings Yield | 1.56% |
| Operating Earnings Yield | 5.14% |
| Normalized Earnings Yield | 2.848 |